| Literature DB >> 33017643 |
Julian Madrid1, David H Benninger2.
Abstract
Parkinson's disease (PD) is becoming a major public-health issue in an aging population. Available approaches to treat advanced PD still have limitations; new therapies are needed. The non-invasive brain stimulation (NIBS) may offer a complementary approach to treat advanced PD by personalized stimulation. Although NIBS is not as effective as the gold-standard levodopa, recent randomized controlled trials show promising outcomes in the treatment of PD symptoms. Nevertheless, only a few NIBS-stimulation paradigms have shown to improve PD's symptoms. Current clinical recommendations based on the level of evidence are reported in Table 1 through Table 3. Furthermore, novel technological advances hold promise and may soon enable the non-invasive stimulation of deeper brain structures for longer periods.Entities:
Keywords: DBS; Non-invasive brain stimulation; Parkinson’s disease; rTMS; tACS; tDCS; tRNS
Mesh:
Year: 2020 PMID: 33017643 DOI: 10.1016/j.jneumeth.2020.108957
Source DB: PubMed Journal: J Neurosci Methods ISSN: 0165-0270 Impact factor: 2.390